Biobeat closed a $50M Series B, led by Ally Bridge, OrbiMed, and Elevage, to expand U.S. commercialization of its 24 hour FDA ...
A recently published study in the New England Journal of Medicine shows that 24-hour ambulatory blood pressure monitoring is a better predictor of cardiovascular and all-cause mortality than just ...
A pilot program between RWJBarnabas Health and the Liberty Science Center‘s SciTech Scity Healthcare Innovation Engine is showing the vast potential of digital health solutions. Biobeat, a medtech ...
NEW YORK (Reuters Health) - For tracking heart risk, taking blood pressure readings regularly at home beats out measurements in the doctor's office, or even expensive 24-hour blood pressure monitoring ...
The study found that people with normal readings in both positions had the lowest risk of heart problems. People with high ...
SEOUL, South Korea, Nov. 19, 2024 /PRNewswire/ -- Sky Labs, a health-tech startup based in South Korea, developed CART BP—the world's first ring-shaped, cuffless device designed for 24-hour blood ...
Hosted on MSN
Scientists make major blood pressure breakthrough with new drug that offers 24 hour protection
A newly developed drug has been found to offer 24 hour protection from high blood pressure, including early mornings when the risk of heart attacks and stroke is highest. Blood pressure is strongly ...
There are several blood pressure monitors on the market, but few reliable smartwatches with that functionality. Chinese tech brand Huawei's Watch D2 could change that. Huawei's Watch D2 includes an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback